Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5-oxoprolinase is a cytoplasmic ATP-dependent enzyme essential for converting 5-oxo-L-proline to L-glutamate, operating as part of the gamma-glutamyl cycle that maintains glutathione homeostasis and amino acid metabolism[4][5][6][8]. Deficiency results in excess 5-oxoproline (5-oxoprolinuria), a rare inherited metabolic disorder with diverse systemic and neurological symptoms, highlighting the enzyme's importance in cellular redox balance and metabolic stress response[8].
For inhibitors, competitive inhibition of the enzyme’s ATP-dependent hydrolytic activity, resulting in accumulation of 5-oxoproline and interfering with glutathione recycling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-oxoprolinase (OPLAH).